Investor Relations

Advanced therapies for the sports medicine and severe burn care markets

Investor Relations

Press Releases

Press Releases

Date Title and Summary Additional Formats
Toggle Summary Aastrom Awarded NIH Grant for Study to Enhance Dendritic Cell-Based Cancer Vaccines Utilizing the AastromReplicell
-- Aastrom's Proprietary Technology Provides Method of Cell Production and Antigen Loading Needed to Improve Vaccines --
View HTML
Toggle Summary Aastrom Biosciences Announces Appointment of Janet M. Hock, B.D.S., Ph.D. As Vice President Global Research
Aastrom Biosciences Announces Appointment of Janet M. Hock, B.D.S., Ph.D. As Vice President Global Research Ann Arbor, Michigan, September 14, 2004 -- Aastrom Biosciences, Inc. (NasdaqSC: ASTM) today announced the appointment of Janet M. Hock, B.D.S., Ph.D. as Vice President Global Research. Dr.
View HTML
Toggle Summary Aastrom Biosciences' CEO to Present at Roth Capital Partners New York Conference
Aastrom Biosciences' CEO to Present at Roth Capital Partners New York Conference Ann Arbor, Michigan, September 9, 2004 -- Aastrom Biosciences, Inc. (NasdaqSC: ASTM) announced today that R. Douglas Armstrong, Ph.D., Chief Executive Officer and Chairman, will present at the Roth Capital Partners New
View HTML
Toggle Summary Aastrom Biosciences, Inc. Reports Fourth Quarter 2004 Financial Results
Aastrom Biosciences, Inc. Reports Fourth Quarter 2004 Financial Results Ann Arbor, Michigan, September 8, 2004 -- Aastrom Biosciences, Inc. (NasdaqSC: ASTM) today reported financial results for the fourth quarter and fiscal year ended June 30, 2004.  The Company also reported significant
View HTML
Toggle Summary Aastrom Biosciences to Hold Investor Conference Call
Aastrom Biosciences to Hold Investor Conference Call Ann Arbor, Michigan, September 7, 2004 -- Aastrom Biosciences, Inc. (NasdaqSC: ASTM) today announced that it will hold an investor conference call on Wednesday, September 8, 2004 at 11:00 a.m. (EDT).
View HTML
Toggle Summary Aastrom Biosciences to Hold Investor Conference Call Tomorrow
Aastrom Biosciences to Hold Investor Conference Call Tomorrow Ann Arbor, Michigan, September 7, 2004 -- Aastrom Biosciences, Inc. (NasdaqSC: ASTM) today announced that it will hold an investor conference call tomorrow, Wednesday, September 8, 2004 at 11:00 a.m. (EDT).
View HTML
Toggle Summary Aastrom Biosciences Appoints James A. Cour as President and COO
Aastrom Biosciences Appoints James A. Cour as President and COO Ann Arbor, Michigan, July 6, 2004 -- Aastrom Biosciences, Inc. (NasdaqSC: ASTM) announced today the appointment of James A. Cour as President and Chief Operating Officer. Mr. Cour will be responsible for the day-to-day operations of
View HTML
Toggle Summary Aastrom Biosciences Expands Bone Graft Clinical Trial to Include University of Michigan
-- Enrollment Open for Repair of Severe Leg Fractures at Orthopedic Trauma Center Using Company's Adult Stem Cell Product --
View HTML
Toggle Summary Aastrom Biosciences' CEO to Present at Rodman & Renshaw Techvest Global Healthcare Conference
Aastrom Biosciences' CEO to Present at Rodman & Renshaw Techvest Global Healthcare Conference Ann Arbor, Michigan, May 6, 2004 -- Aastrom Biosciences, Inc. (NasdaqSC: ASTM) today announced that R. Douglas Armstrong, Ph.D., Chairman, President and Chief Executive Officer, will present at the Rodman
View HTML
Toggle Summary Aastrom Biosciences, Inc. Reports Third Quarter Fiscal Year 2004 Financial Results
Aastrom Biosciences, Inc. Reports Third Quarter Fiscal Year 2004 Financial Results Ann Arbor, Michigan, April 29, 2004 -- Aastrom Biosciences, Inc. (NasdaqSC: ASTM), today reported financial results for the third quarter of fiscal year 2004 ended March 31, 2004.
View HTML

Day High:
Day Low:
Volume:
on
Data Provided by Refinitiv. Minimum 15 minutes delayed.